Würzburg

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Liver and biliary tract cancer1 trial
• Melanoma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Bristol-Myers Squibb2 trials

Running trials

• Active, not recruiting

  A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation

  NCT03383458· Phase 3· Bristol-Myers Squibb· Source

Closed trials

• Withdrawn

  Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

  NCT04495010· Phase 2· Bristol-Myers Squibb· Source